AUD 0.02
(N/A%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 | 7.93 Million AUD | 7.61% |
2023 | 7.37 Million AUD | -76.62% |
2022 | 31.52 Million AUD | -11.67% |
2021 | 35.68 Million AUD | 5.7% |
2020 | 33.76 Million AUD | -11.44% |
2019 | 38.12 Million AUD | 5.58% |
2018 | 36.1 Million AUD | 18.51% |
2017 | 30.47 Million AUD | 3.48% |
2016 | 29.44 Million AUD | 19.82% |
2015 | 24.57 Million AUD | 9.47% |
2014 | 22.44 Million AUD | 19.68% |
2013 | 18.75 Million AUD | 2.05% |
2012 | 18.38 Million AUD | -7.27% |
2011 | 19.82 Million AUD | -6.29% |
2010 | 21.15 Million AUD | 6.63% |
2009 | 19.83 Million AUD | 1.29% |
2008 | 19.58 Million AUD | 17.58% |
2007 | 16.65 Million AUD | 0.0% |
2005 | 4.89 Million AUD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 FY | 7.93 Million AUD | 7.61% |
2024 Q4 | 7.93 Million AUD | 0.0% |
2024 Q2 | 8.12 Million AUD | 0.0% |
2023 Q2 | 28.76 Million AUD | 0.0% |
2023 FY | 7.37 Million AUD | -76.62% |
2023 Q4 | 7.37 Million AUD | 0.0% |
2022 Q4 | 31.52 Million AUD | 0.0% |
2022 FY | 31.52 Million AUD | -11.67% |
2022 Q2 | 35.42 Million AUD | 0.0% |
2021 Q4 | 35.68 Million AUD | 0.0% |
2021 FY | 35.68 Million AUD | 5.7% |
2021 Q2 | 37.77 Million AUD | 0.0% |
2020 Q4 | 33.76 Million AUD | 0.0% |
2020 FY | 33.76 Million AUD | -11.44% |
2020 Q2 | 35.01 Million AUD | 0.0% |
2019 FY | 38.12 Million AUD | 5.58% |
2019 Q2 | 34.1 Million AUD | 0.0% |
2019 Q4 | 38.12 Million AUD | 0.0% |
2018 Q4 | 36.1 Million AUD | 0.0% |
2018 Q2 | 30.14 Million AUD | 0.0% |
2018 FY | 36.1 Million AUD | 18.51% |
2017 Q2 | 32.72 Million AUD | 0.0% |
2017 FY | 30.47 Million AUD | 3.48% |
2017 Q4 | 30.47 Million AUD | 0.0% |
2016 Q4 | 29.44 Million AUD | 0.0% |
2016 Q2 | 30.16 Million AUD | 0.0% |
2016 FY | 29.44 Million AUD | 19.82% |
2015 Q4 | 24.57 Million AUD | 0.0% |
2015 FY | 24.57 Million AUD | 9.47% |
2015 Q2 | 23.2 Million AUD | 0.0% |
2014 Q2 | 18.69 Million AUD | 0.0% |
2014 FY | 22.44 Million AUD | 19.68% |
2014 Q4 | 22.44 Million AUD | 0.0% |
2013 Q2 | 17.51 Million AUD | 0.0% |
2013 Q4 | 18.75 Million AUD | 0.0% |
2013 FY | 18.75 Million AUD | 2.05% |
2012 FY | 18.38 Million AUD | -7.27% |
2012 Q4 | 18.38 Million AUD | 0.0% |
2011 FY | 19.82 Million AUD | -6.29% |
2011 Q4 | 19.82 Million AUD | 0.0% |
2010 Q4 | 21.15 Million AUD | 0.0% |
2010 FY | 21.15 Million AUD | 6.63% |
2009 FY | 19.83 Million AUD | 1.29% |
2009 Q4 | 19.83 Million AUD | 0.0% |
2008 FY | 19.58 Million AUD | 17.58% |
2008 Q4 | 19.58 Million AUD | 0.0% |
2007 FY | 16.65 Million AUD | 0.0% |
2007 Q4 | 16.65 Million AUD | 0.0% |
2005 FY | 4.89 Million AUD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
4DMedical Limited | 120.01 Million AUD | 93.392% |
Adherium Limited | 9.88 Million AUD | 19.785% |
Aroa Biosurgery Limited | 101.82 Million AUD | 92.211% |
Atomo Diagnostics Limited | 11.37 Million AUD | 30.302% |
Anteris Technologies Ltd | 45.7 Million AUD | 82.646% |
Control Bionics Limited | 9.02 Million AUD | 12.144% |
CardieX Limited | 12.64 Million AUD | 37.303% |
Compumedics Limited | 40.35 Million AUD | 80.348% |
Cochlear Limited | 2.74 Billion AUD | 99.711% |
CleanSpace Holdings Limited | 26.05 Million AUD | 69.557% |
Cyclopharm Limited | 45.91 Million AUD | 82.726% |
EMVision Medical Devices Ltd | 23.97 Million AUD | 66.915% |
Nova Eye Medical Limited | 29.88 Million AUD | 73.459% |
HeraMED Limited | 2.95 Million AUD | -168.657% |
Imricor Medical Systems, Inc. | 12.17 Million AUD | 34.864% |
ImpediMed Limited | 46.98 Million AUD | 83.121% |
InhaleRx Limited | 1.57 Million AUD | -402.954% |
Micro-X Limited | 26.89 Million AUD | 70.511% |
Neurotech International Limited | 12.21 Million AUD | 35.063% |
OncoSil Medical Limited | 6.71 Million AUD | -18.049% |
PolyNovo Limited | 109.16 Million AUD | 92.735% |
Respiri Limited | 6.19 Million AUD | -28.107% |
SomnoMed Limited | 69.8 Million AUD | 88.638% |
Universal Biosensors, Inc. | 30.12 Million AUD | 73.669% |
Uscom Limited | 5.13 Million AUD | -54.461% |
Visioneering Technologies, Inc. | 11.2 Million AUD | 29.222% |